- Home
- About
- Find staff
- Ingela Franck Lissbrant
Ingela Franck Lissbrant
Affiliated to Research
Department of-
Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in
Sweden
Ulf Strömberg, Anders Berglund, Stefan Carlsson, Camilla Thellenberg Karlsson, Mats Lambe, Ingela Franck Lissbrant, Par Stattin, Ola Bratt
INTERNATIONAL JOURNAL OF CANCER - 2024 -
Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in
Sweden
Rolf Gedeborg, Fredrik Sandin, Camilla Thellenberg-Karlsson, Johan Styrke, Ingela Franck-Lissbrant, Hans Garmo, Pär Stattin
Scandinavian journal of urology - 2023 -
Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in
Sweden.
Pär Stattin, Marcus Westerberg, Ingela Franck Lissbrant, Marie Hjälm Eriksson, Anders Kjellman, Anders Ullén, Zdravko Vassilev, Per Sandstrom, Rachel Weinrib, David Martinez, Xabier Garcia-Albeniz
Clinical genitourinary cancer - 2023 -
Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health
records
Charlotte Alverbratt, H. Vikman, M. Hjälm Eriksson, P. Stattin, Ingela Franck-Lissbrant
Scandinavian Journal of Urology - 2022 -
Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization
study.
Rolf Gedeborg, Hans Garmo, Camilla Thellenberg-Karlsson, Giuseppe Fallara, Johan Styrke, Ingela Franck Lissbrant, Pär Stattin
Acta oncologica (Stockholm, Sweden) - 2022 -
Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of
Sweden
G. Fallara, Charlotte Alverbratt, H. Garmo, H. Vikman, M. H. Eriksson, Ingela Franck-Lissbrant, P. Stattin
Acta Oncologica - 2021 -
Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in
Sweden
G. George, H. Vikman, R. Gedeborg, Ingela Franck-Lissbrant, H. Garmo, J. Styrke, M. Van Hemelrijck, P. Stattin
Acta Oncologica - 2021 -
Rapid ascertainment of uptake of a new indication for abiraterone by use of three nationwide health care registries in
Sweden.
Giuseppe Fallara, Ingela Franck Lissbrant, Johan Styrke, Francesco Montorsi, Rolf Gedeborg, Fredrik Sandin, Pär Stattin
Acta oncologica (Stockholm, Sweden) - 2021 -
Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19
pandemic
G. Fallara, F. Sandin, J. Styrke, S. Carlsson, Ingela Franck Lissbrant, J. Ahlgren, Ola Bratt, M. Lambe, P. Stattin
Scandinavian Journal of Urology - 2021 -
The value of real-world data in understanding prostate cancer risk and improving clinical care: Examples from Swedish
registries
K. Beckmann, H. Garmo, Ingela Franck Lissbrant, P. Stattin
Cancers - 2021 -
Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in
Sweden
J. Svensson, Ingela Franck-Lissbrant, O. Gauffin, M. Hjalm-Eriksson, S. Kilany, K. Fagerlund, P. Stattin
Scandinavian Journal of Urology - 2021 -
Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year
journey
Johan Stranne, Elin Axén, Ingela Franck Lissbrant, P. Fransson, Maria Frånlund, Jonas Hugosson, Ali Khatami, Katarina Koss-Modig, Pär Lodding, Maria Nyberg, P. Stattin, Ola Bratt
World Journal of Urology - 2020 -
Radical radiotherapy for prostate cancer: patterns of care in Sweden
1998-2016
K. Beckmann, H. Garmo, P. Nilsson, Ingela Franck Lissbrant, A. Widmark, P. Stattin
Acta Oncologica - 2020 -
Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort
Study.
Andreas Pettersson, Daniel Alm, Hans Garmo, Marie Hjelm Eriksson, Enrique Castellanos, Lennart Åström, Jon Kindblom, Anders Widmark, Adalsteinn Gunnlaugsson, Ingela Franck Lissbrant, Per Nilsson, Pär Stattin
JNCI cancer spectrum - 2020 -
Observational study on time on treatment with abiraterone and
enzalutamide
G. Fallara, Ingela Franck Lissbrant, J. Styrke, F. Montorsi, H. Garmo, P. Stattin
Plos One - 2020 -
Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in
Sweden
A. W. Orrason, M. Westerberg, H. Garmo, Ingela Franck Lissbrant, D. Robinson, P. Stattin
Bju International - 2020 -
Set-up and preliminary results from the Patient-overview Prostate Cancer. Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of
Sweden
Ingela Franck Lissbrant, M. Hjälm Eriksson, M. Lambe, M. Törnblom, P. Stattin
Scandinavian Journal of Urology - 2020 -
Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based
study
M. Westerberg, Ingela Franck Lissbrant, Jan-Erik Damber, D. Robinson, H. Garmo, P. Stattin
Acta Oncologica - 2020 -
Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of
Sweden
W. Cazzaniga, E. Ventimiglia, M. Alfano, D. Robinson, Ingela Franck Lissbrant, S. Carlsson, J. Styrke, F. Montorsi, A. Salonia, P. Stattin
Frontiers in Medicine - 2019 -
Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational
Study
D. Robinson, H. Garmo, Ingela Franck Lissbrant, A. Widmark, A. Pettersson, A. Gunnlaugsson, J. Adolfsson, O. Bratt, P. Nilsson, P. Stattin
European Urology - 2018 -
Public online reporting from a nationwide population-based clinical prostate cancer
register.
Pär Stattin, Fredrik Sandin, Stacy Loeb, David Robinson, Ingela Franck-Lissbrant, Mats Lambe
BJU international - 2018 -
Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in
Sweden
Ingela Franck Lissbrant, E. Ventimiglia, D. Robinson, M. Tornblom, M. Hjalm-Eriksson, M. Lambe, Y. Folkvaljon, P. Stattin
Scandinavian Journal of Urology - 2018 -
Castration is a prerequisite for the inhibitory effect of metronomic chemotherapy on the growth of experimental castration-resistant prostate
cancer.
Åsa Jellvert, Daniel Åhs, Josefin Olausson, Ingela Franck Lissbrant, Jan-Erik Damber, Karin Welén
Acta oncologica (Stockholm, Sweden) - 2018 -
The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European
data
M. Lycken, L. Drevin, H. Garmo, P. Stattin, J. Adolfsson, Ingela Franck-Lissbrant, L. Holmberg, A. Bill-Axelson
European Journal of Cancer - 2018 -
Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based
study.
Anna Kristiansen, Linda Drevin, Brett Delahunt, Hemamali Samaratunga, David Robinson, Ingela Franck-Lissbrant, Pär Stattin, Lars Egevad
Pathology - 2017 -
Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based
Study.
Frederik Birkebæk Thomsen, Fredrik Sandin, Hans Garmo, Ingela Franck-Lissbrant, Göran Ahlgren, Mieke Van Hemelrijck, Jan Adolfsson, David Robinson, Pär Stattin
European urology - 2017 -
Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based
Study
P. Stattin, F. Sandin, F. B. Thomsen, H. Garmo, D. Robinson, Ingela Franck-Lissbrant, H. Jonsson, O. Bratt
European Urology - 2017 -
The National Prostate Cancer Register of Sweden: Basis for quality assessment, quality improvement, and
research
P. Stattin, F. Sandin, K. Hellström, D. Robinson, Ingela Franck-Lissbrant
Tijdschrift voor Urologie - 2017 -
Population-based study of long-term functional outcomes after prostate cancer
treatment.
Sigrid Carlsson, Linda Drevin, Stacy Loeb, Anders Widmark, Ingela Franck-Lissbrant, David Robinson, Eva Johansson, Pär Stattin, Per Fransson
BJU international - 2016 -
Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer: A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical
Practice
M. Reza, M. Ohlsson, R. Kaboteh, A. Anand, Ingela Franck Lissbrant, Jan-Erik Damber, A. Widmark, C. Thellenberg-Karlsson, L. Budäus, T. Steuber, T. Eichenauer, P. Wollmer, L. Edenbrandt, E. Trägårdh, A. Bjartell
European Urology Focus - 2016 -
Dashboard report on performance on select quality indicators to cancer care
providers.
Pär Stattin, Fredrik Sandin, Torsten Sandbäck, Jan-Erik Damber, Ingela Franck-Lissbrant, David Robinson, Ola Bratt, Mats Lambe
Scandinavian journal of urology - 2016 -
Population-based study on use of chemotherapy in men with castration resistant prostate
cancer
Ingela Franck-Lissbrant, H. Garmo, A. Widmark, P. Stattin
Acta Oncologica - 2013 -
Effective oral combination metronomic chemotherapy with low toxicity for the management of castration-resistant prostate
cancer.
Åsa Jellvert, Ingela Franck-Lissbrant, Maliha Edgren, Elisabeth Ovferholm, Karin Braide, Ann-Marie Ekelund Olvenmark, Jon Kindblom, Per Albertsson, Bo Lennernäs
Experimental and therapeutic medicine - 2011 -
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II
study.
Bo Lennernäs, Ingela Franck-Lissbrant, Hans Lennernäs, Karl Mikael Kälkner, Rob Derrick, Julian Howell
Palliative medicine - 2010 -
High precision transponder localization using a novel electromagnetic positioning system in patients with localized prostate
cancer.
Jon Kindblom, Ann-Marie Ekelund Olvenmark, Hanna Syren, Roman Iustin, Karin Braide, Ingela Franck-Lissbrant, Bo Lennernäs
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology - 2009